Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis

Expert Review of Molecular Diagnostics

Volumn 12, Issue 6, 2012, Pages 549-551

  Wood, Robin ^a   Lawn, Stephen D ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

diagnostics; HIV; immune complex; LAM; lipoarabinomannan; tuberculosis

Indexed keywords

LIPOARABINOMANNAN;

ACTINOMYCES; ANTIBODY RESPONSE; ANTIGEN DETECTION; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFLUENZAE; HIV ASSOCIATED TUBERCULOSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; MYCOBACTERIUM TUBERCULOSIS; POINT OF CARE TESTING; REVIEW; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; URINALYSIS; URINE ANTIGEN TEST;

ANTIGENS, BACTERIAL; COINFECTION; DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84864624053     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.52     Document Type: Review

References (20)

1. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: Progress and challenges. Clin. Chest Med. 30(4), 701-716 (2009).
2. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: Systematic review and meta-analysis. Eur. Respir. J. 38(6), 1398-1405 (2011).
3. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycoconjugates: Structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev. 35(6), 1126-1157 (2011).
4. Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr. Res. 338(23), 2539-2547 (2003).
5. Demkow U, Filewska M, Michalowska-Mitczuk D et al. Heterogeneity of antibody response to myobacterial antigens in different clinical manifestations of pulmonary tuberculosis. J. Physiol. Pharmacol. 58(Suppl. 5 Pt 1), 117-127 (2007).
6. Tessema TA, Bjune G, Hamasur B, Svenson S, Syre H, Bjorvatn B. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand. J. Infect. Dis. 34(2), 97-103 (2002).
7. Arias-Bouda LMP, Kuijper S, Van Der Werf A, Nguyen LN, Jansen HM, Kolk AHJ. Changes in avidity and level of immunoglobulin G antibodies to Mycobacterium tuberculosis in sera of patients undergoing treatment for pulmonary tuberculosis. Clin. Diagn. Lab. Immunol. 10(4), 702-709 (2003).
8. WHO. WHO (2011) Policy Statement: COMMERCIAL Serodiagnostic Tests for Diagnosis of Tuberculosis. WHO, Geneva, Switzerland (2011).
9. Hamasur B, Bruchfeld J, Haile M et al. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J. Microbiol. Methods 45(1), 41-52 (2001).
10. Glatman-Freedman A, Mednick AJ, Lendvai N, Casadevall A. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infect. Immun. 68(1), 335-341 (2000).
11. Bhattacharya A, Ranadive SN, Kale M, Battacharya S. Antibody-based enzyme-linked immunosorbent assay for determination of immune complexes in clinical tuberculosis. Am. Rev. Respir. Dis. 134, 205-209 (1986).
12. Roberts-Thomsom PJ, Shepherd K. Molecular size heterogeneity of immunoglobulins in health and disease. Clin. Exp. Immunol. 79, 328-334 (1990).
13. Wood R, Racow K, Bekker L-G et al. Lipoarabinomannan in urine during tuberculosis treatment: Association with host and pathogen factors and mycobacteriuria. BMC Infect. Dis. 12(1), 47 (2012).
14. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whielaw A, Wood R. Characteristics and early outcomes with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin. Infect. Dis. 54(8), 1071-1079 (2012).
15. Boehme CC, Nabeta P, Hilleman D et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363, 1005-1015 (2010).
16. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F. Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications and informationreasources. Inst. Lab. Anim. Res. J. 46, 943-954 (2005).
17. Ritter MA. Polyclonal and monoclonal antibodies. Methods Mol. Med. 40, 23-34 (2000).
18. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect. Dis. 9, 173-184 (2009).
19. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker L-G, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23(14), 1875-1880 (2009).
20. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: A descriptive study. Lancet Infect. Dis. 12(3), 383-392 (2012).